A Randomized Trial of Multivitamin Supplements and HIV Disease Progression and Mortality A low-cost regimen of multivitamin supplements effectively delays the progression of HIV disease and initiation of antiretroviral therapy in HIV-infected women. New England Journal of Medicine, July 1, 2004
	Intrapartum Exposure to Nevirapine and Subsequent Maternal Responses to Nevirapine-Based Antiretroviral Therapy Women who receive intrapartum nevirapine are less likely to have virologic suppression. New England Journal of Medicine, July 15, 2004
	Single-Dose Perinatal Nevirapine plus Standard Zidovudine to Prevent Mother-to-Child Transmission of HIV-1 in Thailand The rate of mother-to-child transmission of HIV can effectively be reduced with a dose of nevirapine and zidovudine during pregnancy. New England Journal of Medicine, July 15, 2004
	HAI's Joint Statement of Support: South Africa Implements Plan for Comprehensive Treatment and Care for HIV and AIDS Approval of the last component to the HIV/AIDS-STD Strategic Plan for South Africa 2000-2005. November, 2003 (PDF format)
	Botswana and Harvard: Teaming Up to Find an AIDS Vaccine Institute Chairman Max Essex spoke about the Botswana HAI Partnership with Jenny Badner. Voice of America, August 2003
	HAI Helps Launch HIV Vaccine Trial in Botswana The first prophylactic HIV vaccine trial conducted in southern Africa was launched. Harvard Public Health NOW, August 2003
	Joint Letter from 100 Leading Health and AIDS Experts Calling on President Bush to Commit to New AIDS Initiative HAI leaders join with other experts calling on President Bush to commit to new AIDS initiative. Physicians for Human Rights, January 2003
	Former Zambia President Speaks at HSPH during Day Devoted to AIDS Programs Kenneth Kaunda, former president of Zambia, delivered a rousing speech at HSPH on November 25 that brought more than 180 people in Snyder Auditorium to their feet. Harvard Public Health Now, December 2002
	HAI Receives Beal Endowment In support of its work, HAI receives Beal endowment to fund its research directorship. Harvard University Gazette, September 19, 2002
	They Brought Me Back from Death The Enhancing Care Initiative and health workers at the Church of Scotland Hospital in Tugela Ferry develop a groundbreaking care program for patients who cannot be admitted to hospital. Sunday Times of South Africa, August 2002
	Mogae Wins US Awards 2001 HAI Leadership Award recipient, President Festus Mogae of Botswana, wins additional awards. Republic of Botswana Daily News Online, August 2002
	Botswana's AIDS Laboratory Squares up to HIV Pandemic At Princess Marina Hospital in Gaborone, Botswana, ninety scientists and technicians work at the Botswana-HAI Partnership HIV Reference Laboratory, Africa's largest laboratory dedicated to AIDS research. The two main objectives of the laboratory are to determine the long-term effects of drug treatment and to contribute towards the development of an effective vaccine for the virus. Much work will be done mapping the genetic code of the virus and analyzing whether the sub-type HIV-1C spreads more rapidly than other sub-types. Dr. Hermann Bussmann, head of the research effort on drug resistance at the Botswana-HAI Partnership said he was "pleased to be fighting the pandemic in the region where it is most needed." Nature, July 2002. for full text go to http://www.nature.com/nature
	Online Chat HAI Chairman Max Essex spoke about the AIDS epidemic in Botswana with Lynn Neary of NPR's "All Things Considered". NPR, July 2002
	Botswana Wages War on AIDS President Festus Mogae, along with American partners including HAI, is making unprecedented efforts toward halting the AIDS epidemic in Botswana. President Mogae has initiated the most sweeping anti-AIDS campaign in the world with the goal of having no infections by 2016. The campaign includes an intensive HIV prevention effort and free treatment nationwide. The government also helped to build the Botswana-HAI HIV Reference Laboratory, which will test and analyze data, research resistance to drug therapy, and undertake HIV vaccine research. The diamond giant Debswana, Botswana's largest company, has also joined the fight providing treatment and prevention education for its employees. USA Today, May 2002. For full text go to http://www.usatoday.com
	Good and Bad News from AIDS Vaccine Tests An editorial written by HAI researcher published in Kenyan newspaper March 2002
	HIV Vaccines and the Community, Community Advisory Board Bulletin Scientisist from Botswana-Harvard Partnership speak at the 12th International Conference on AIDS and STDS in Africa. February 2002
	Essex Moves to Botswana to Open Lab, Launch AIDS Vaccine Study June 2001
	Transcript of CNN chat about medical care for HIV patients in Africa March 2000
	Botswana Comes to Grips with AIDS This article commends the efforts of the Botswana-HAI HIV Reference Laboratory, which is at the forefront of the drive to bring advanced AIDS drugs and therapy to Africa. As anti-retroviral drugs are in such short supply in Africa, many people feel discouraged from getting tested. The HIV Reference laboratory will not only make HIV testing and treatment easier, it will be the first laboratory in the world to specifically research the subtype of HIV (HIV-1C) that has hit Africa the hardest. In-country research of this subtype will also assist in developing an Africa-specific HIV vaccine. Boston Globe, February 2000. For full text go to http://www.boston.com/globe/search/
	The New AIDS Epidemic Harvard Magazine, September-October 1999